Skip to main content
GutCited
Fig 1. Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis. Differentially expressed genes from mucosal tissue biopsy samples in the sigmoid colon of patients dia
Figure 2. Fig 1. Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis. Differentially expressed genes from mucosal tissue biopsy samples in the sigmoid colon of patients diagnosed with irritable bowel syndrome (IBS) and non-IBS patients (control). The heat map (adapted from Dussik et al.) displayed differential expression of 858 genetic features between the two experimental groups (p-value < 0.05) [68]. Pronounced clusters of similar color and intensity are also visible with blue indicative of individual biomarkers with lower expression levels and red illustrating higher levels of expression.

Mô tả

Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis.

Cite This Figure

![Figure 2: Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis.](https://pdfs.citedhealth.com/figures/36264926/368.png)

> Source: Aleksandra Grozić et al. "Identification of putative transcriptomic biomarkers in irritable bowel syndrome." *PloS one*, 2022. PMID: [36264926](https://pubmed.ncbi.nlm.nih.gov/36264926/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/36264926/368.png" alt="Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis." />
  <figcaption>Figure 2. Workflow and DNA microarray analysis. Workflow in the acquisition of an IBS genetic “fingerprint” from patient sample to transcriptomic analysis.<br>  Source: Aleksandra Grozić et al. "Identification of putative transcriptomic biomarkers in irritable bowel syndrome." <em>PloS one</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36264926/">36264926</a></figcaption>
</figure>